Tilson Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$379K Sell
1,552
-7
-0.4% -$1.63K 0.11% 64
2025
Q4
$323K Sell
1,559
-129
-8% -$25.5K 0.1% 67
2025
Q3
$313K Buy
1,688
+138
+9% +$23.6K 0.1% 64
2025
Q2
$237K Buy
1,550
+13
+0.8% +$2K 0.09% 66
2025
Q1
$255K Buy
1,537
+31
+2% +$4.85K 0.1% 65
2024
Q4
$218K Buy
1,506
+42
+3% +$6.51K 0.09% 70
2024
Q3
$237K Buy
+1,464
New +$233K 0.1% 66
2024
Q2
Sell
-1,593
Closed -$252K 53
2024
Q1
$252K Buy
1,593
+88
+6% +$14K 0.14% 64
2023
Q4
$236K Buy
1,505
+47
+3% +$7.21K 0.15% 59
2023
Q3
$227K Buy
+1,458
New +$241K 0.18% 57
2023
Q2
Sell
-1,522
Closed -$236K 43
2023
Q1
$236K Buy
1,522
+5
+0.3% +$807 0.19% 54
2022
Q4
$268K Buy
+1,517
New +$262K 0.23% 52

Other funds holding JNJ

Tilson Financial Group's JNJ Position: Q1 2026 in Review

Tilson Financial Group reduced its Johnson & Johnson (JNJ) stake by 0.45% in Q1 2026, selling an estimated $1.63K and leaving 1,552 shares worth $379K. The position accounts for 0.11% of the portfolio, ranked #64.

Tilson Financial Group first reported a position in JNJ in Q4 2022 and has held it in 12 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Tilson Financial Group held 1,552 shares of Johnson & Johnson worth $379K as of Q1 2026.
  • Tilson Financial Group sold 7 Johnson & Johnson shares in Q1 2026, an estimated $1.63K.
  • Johnson & Johnson made up 0.11% of Tilson Financial Group's portfolio in Q1 2026, its #64 holding.
  • Tilson Financial Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 12 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Tilson Financial Group's 13F filing for Q1 2026, filed 29 Apr 2026.